期刊文献+

钙粘素E和基质金属蛋白酶检测与肝癌预后关系研究 被引量:1

The Study on Relationship between E-cadherin, MMP-2 and MMP-9' expressions and the prognosis of hepatolellular carcinoma.
暂未订购
导出
摘要 探讨钙粘素E(E -cadherin) ,基质金属蛋白酶 (matrixmetalloproteinase,MMPs)MMP - 2、MMP - 9在肝癌侵袭转移中的作用 ;利用免疫组化学染色对 6 8例肝癌手术切除石蜡包埋标本进行E -cadherin、MMP - 2、MMP - 9的检测 ,并结合临床病理指标 (Edmondson分级、侵袭转移倾向 )进行分析。E -cadherin、MMP - 9在侵袭转移倾向高危组和低危组中有显著性差异 ;E -cadherin在不同恶性程度肝癌组织中有显著性差异。E -cadherin、MMP - 9的异常表达与肝癌分期和侵袭转移有关。检测E -cadherin、MMP - 2、MMP - 9等可为临床预后提供有价值的参考指标。 To investigate the effect of E-cadherin, MMP-2 and MMP-9 on invasion and metastasis of hepatocellular carcinoma(HCC); Surgical samples from 68 cases of HCC and their peritumorous tissues were detected by immunohistochemical technique In the group of high potential in vasion and mestastasis of HCC, the expressions of E-cadherin MMP-2 and MMP-9 were 9%, 42% and 61%, respectively, while in low potential group, they were 29%, 34% and 34%, respectively. There was a correlation between the expression of MMP-9 and the tumor invasion and metastasis in HCC ( P <0 05)and a reverse correlation between the expression of E-cadherin and the tumor invasion and metastasis potential in HCC ( P <0 05). The expression of E-cadherin was significantly correlated with the differentiation of HCC. The positive rates in Edmondson's HCC Ⅳ grade were lower than that, in Ⅱ grade ( P <0 01). The abnormal expressions of E-cadherin and MMP-9 were correlated with Edmondson's grade and the invasion and metastasis of HCC. E-cadherin MMP-2 and MMP-9 may be useful diagnostic parameters for the tumor invasion and metastasis in HCC.
出处 《临床肝胆病杂志》 CAS 北大核心 2002年第4期235-236,共2页 Journal of Clinical Hepatology
关键词 肝癌 预后 E-钙粘素 基质金属蛋白酶 肿瘤浸润 免疫组织化学 肿瘤转移 E-cadherin matrix metalloproteinase (MMPs) liver neoplasms invasion and metastasis
  • 相关文献

参考文献5

  • 1[1]Osada T, Sakamoto M, lno Y, et al. E - cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma [ J ]. Hepatology,1996, 24(6): 1460 - 7.
  • 2[2]Endo K, ueda T, ueyama J, et al. Immunoreactive E - cadherin,Alpha catenin, beta- catenin, and gamma- catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients survival[J]. Hum Pathol, 2000, 31(5): 558 - 65.
  • 3[3]Maatta M, Soini Y, Liakka A, et al. Differential expression of matrix metalloproteinase (MMP) - 2, MMP - 9, andmembrane type 1- MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis [ J ]. Clin Cancer Res, 2000, 6(7) :2726 - 34.
  • 4[4]Sakamoto Y, Mafune K, Mori M, et al. Overexpression of MMP-9 correlates with growth of small hepatoce]lular carcinoma[J]. Int J Oncol, 2000, 17(2) :237 - 43.
  • 5[5]Harada T, Arii S, Mise M, et al. Membrane- type matrix metalloproteinase- 1 (MT1 - MTP) gene is overexpreased in highly invasive bepatocellular carcinomas[J] .J Hepatol, 1998, 28(2) :231 - 9.

同被引文献13

  • 1Mitsiades N, Yu WH, Poulaki V, et al. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res, 2001, 61(2): 577-581.
  • 2Jiang Y, Wang M, Celiker MY, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res, 2001, 61(6): 2365-2370.
  • 3Schoedel KE, Tyner VZ, Kim TH, et al. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Mod Pathol, 2003, 16(1): 14-21.
  • 4McKenna GJ, Chen Y, Smith RM, et al. A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg. 2002 May, 183(5): 588-594.
  • 5Kuyvenhoven JP, van-Hoek B, Blom E, et al. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma. Thromb Haemost, 2003, 89(4): 718-725.
  • 6Sela BA. Matrix metalloproteinases: promoters of tumor progression and invasiveness. Isr Med Assoc J,2002, 4(4): 280-282.
  • 7Jurasz P, Sawicki G, Duszyk M, et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.Cancer Res, 2001, 61(1): 376-382.
  • 8Naglich JG, Jure-Kunkel M, Gupta E, et al. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. Cancer Res, 2001, 61(23): 8480-8485.
  • 9蔡阳,吴志全,樊嘉,封光华,贺斌,刘银坤,叶胜龙,汤钊猷.膜型基质金属蛋白酶-1与肝细胞癌侵袭转移性的关系[J].中华肝脏病杂志,2000,8(4):236-238. 被引量:9
  • 10胡劲松,翟为溶,张月娥,马瑾瑜,周筱梅.基质金属蛋白酶及组织抑制剂在肝癌中的表达及与预后的关系[J].中华消化杂志,2001,21(8):461-464. 被引量:12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部